Sirio Pharma Co., Ltd. (SHE:300791)

Sirio Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	579.49	636.03	534.49	1,502	715.54	216.7
Short-Term Investments	-	25.17	20	109.26	-	-
Trading Asset Securities	0.41	115.2	200.66	79.13	530.77	473.49
Cash & Short-Term Investments	579.89	776.4	755.14	1,690	1,246	690.2
Cash Growth	-0.96%	2.81%	-55.32%	35.60%	80.57%	74.56%
Accounts Receivable	760.69	702.53	652.86	476.96	372.33	307.1
Other Receivables	23	20.81	4.99	4.45	4.27	3.13
Receivables	783.69	723.34	657.85	481.41	376.6	310.22
Inventory	578.89	481.66	481.06	232.58	239.61	266.77
Other Current Assets	51.2	41.54	38.87	28.58	51.99	56.64
Total Current Assets	1,994	2,023	1,933	2,433	1,915	1,324
Property, Plant & Equipment	2,155	2,093	1,913	1,332	1,173	768.05
Long-Term Investments	216.02	52.44	94.11	-	337.79	152.22
Goodwill	435.32	417.1	420.73	163.05	158.59	176.28
Other Intangible Assets	527.72	525.92	544.84	178.33	160.75	128.97
Long-Term Deferred Tax Assets	105.57	81.36	32.48	13.75	16.31	33.75
Long-Term Deferred Charges	246.9	258.14	201.92	59.45	53	48.55
Other Long-Term Assets	55.4	34.66	55.99	7.14	6.57	17.98
Total Assets	5,735	5,486	5,196	4,186	3,820	2,650
Accounts Payable	443.6	393.43	398.13	259.25	195.71	199.52
Accrued Expenses	121.11	92.51	104.39	152.33	79.6	71.21
Short-Term Debt	177.4	54.82	-	0.16	0.12	1.61
Current Portion of Long-Term Debt	-	40.59	21.25	-	-	33.1
Current Portion of Leases	-	27.09	42.8	7.26	5.19	-
Current Income Taxes Payable	-	48.07	11.39	11.03	10.18	21.58
Current Unearned Revenue	42.04	36.92	53.13	25.83	28.22	43.11
Other Current Liabilities	250.19	131.1	120.04	13.84	13.43	16.93
Total Current Liabilities	1,034	824.54	751.13	469.69	332.44	387.06
Long-Term Debt	1,162	1,156	1,049	908.36	852.28	-
Long-Term Leases	329.16	328.39	256.16	21.14	16.68	-
Long-Term Unearned Revenue	73.42	59.7	65.68	62.4	61.48	65.25
Long-Term Deferred Tax Liabilities	13.31	15.15	28.08	22.69	12.44	14.64
Other Long-Term Liabilities	459.53	461.44	479.47	0.01	-	-
Total Liabilities	3,072	2,845	2,630	1,484	1,275	466.94
Common Stock	307.32	235.87	181.56	180.5	180.17	120
Additional Paid-In Capital	448.81	500.7	547.5	1,048	1,045	1,081
Retained Earnings	1,631	1,623	1,496	1,278	1,138	978.14
Treasury Stock	-66.16	-54.31	-44.53	-	-	-
Comprehensive Income & Other	232.5	200.88	209.37	195.13	181.35	3.75
Total Common Equity	2,554	2,506	2,390	2,702	2,545	2,183
Minority Interest	110.02	135.36	176.14	-	0.01	0.01
Shareholders' Equity	2,664	2,641	2,566	2,702	2,545	2,183
Total Liabilities & Equity	5,735	5,486	5,196	4,186	3,820	2,650
Total Debt	1,668	1,607	1,369	936.9	874.26	34.71
Net Cash (Debt)	-1,088	-830.1	-614.1	753.08	372.05	655.49
Net Cash Growth	-	-	-	102.42%	-43.24%	121.73%
Net Cash Per Share	-3.57	-2.73	-2.02	2.45	1.16	2.14
Filing Date Shares Outstanding	305.82	306.79	304.67	305.04	304.49	304.2
Total Common Shares Outstanding	305.82	304.96	304.67	305.04	304.49	304.2
Working Capital	959.34	1,198	1,182	1,963	1,582	936.77
Book Value Per Share	8.35	8.22	7.84	8.86	8.36	7.18
Tangible Book Value	1,591	1,563	1,424	2,360	2,225	1,877
Tangible Book Value Per Share	5.20	5.12	4.68	7.74	7.31	6.17
Buildings	-	1,067	1,000	890.28	528.67	478.54
Machinery	-	1,390	1,242	974.19	773.89	645.85
Construction In Progress	-	238.4	186.94	69.28	365.12	117.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.